(5S,9S,11S,12R)-11-((S)-sec-butyl)-1-(9H-fluoren-9-yl)-5,9-diisopropyl-12-Methoxy-4,10-diMethyl-3,6,8-trioxo-2-oxa-4,7,10-triazatetradecan-14-oic acid
Synonyms
Fmoc-3AA-orl;FMOC-3AA-OH;Fmoc-3vvd-OH;Tripeptide (MMAE-3);Fmoc-Meval-val-dolaisoleucine-OH;(5S,8S,11S,12R)-11-((S)-sec-butyl)-1-(9H-fluoren-9-yl)-5,8-diisopropyl-12-methoxy-4,10-dimethyl-3,6,9-trioxo-2-oxa-4,7,10-triazatetradecan-14-oic acid;L-Valinamide, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-N-methyl-L-valyl-N-[(1S,2S)-1-[(1R)-2-carboxy-1-methoxyethyl]-2-methylbutyl]-N-methyl-
Description
(5S,9S,11S,12R)-11-((S)-sec-butyl)-1-(9H-fluoren-9-yl)-5,9-diisopropyl-12-Methoxy-4,10-diMethyl-3,6,8-trioxo-2-oxa-4,7,10-triazatetradecan-14-oic acid is a cleavable ADC linker for antibody-drug conjugate (ADC) synthesis.
Molecular Formula
C36H51N3O7
InChI
JDMOCVJBADMSJP-FCUBIXSHSA-N
InChIKey
JDMOCVJBADMSJP-FCUBIXSHSA-N
SMILES
C(NC(=O)[C@H](C(C)C)N(C(OCC1C2=C(C=CC=C2)C2=C1C=CC=C2)=O)C)(=O)[C@H](C(C)C)N([C@H]([C@H](OC)CC(O)=O)[C@@H](C)CC)C
Boiling Point
793.0±60.0 ℃(Predicted)
Density, g/cm3
1.144±0.06(Predicted)